Nerve growth factor

Source: Wikipedia, the free encyclopedia.
NGF
Gene ontology
Molecular function
Cellular component
Biological process
Sources:Amigo / QuickGO
Ensembl
UniProt
RefSeq (mRNA)

NM_002506

NM_001112698
NM_013609

RefSeq (protein)

NP_002497

NP_001106168
NP_038637

Location (UCSC)Chr 1: 115.29 – 115.34 MbChr 3: 102.38 – 102.43 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

Nerve growth factor (NGF) is a

beta cells and the regulation of the immune system
.

Structure

NGF is initially in a 7S, 130-

kDa
complex of 3 proteins – Alpha-NGF, Beta-NGF, and Gamma-NGF (2:1:2 ratio) when expressed. This form of NGF is also referred to as proNGF (NGF precursor). The gamma subunit of this complex acts as a serine protease, and cleaves the N-terminal of the beta subunit, thereby activating the protein into functional NGF.

The term nerve growth factor usually refers to the 2.5S, 26-kDa beta subunit of the protein, the only component of the 7S NGF complex that is biologically active (i.e. acting as a signaling molecule).

Function

As its name suggests, NGF is involved primarily in the growth, as well as the maintenance, proliferation, and survival of nerve cells (neurons) and is critical for the survival and maintenance of sympathetic and

sensory neurons as they undergo apoptosis in its absence.[5]
However, several recent studies suggest that NGF is also involved in pathways besides those regulating the life cycle of neurons.

Neuronal proliferation

NGF can drive the expression of genes such as bcl-2 by binding to the Tropomyosin receptor kinase A, which stimulates the proliferation and survival of the target neuron.

High affinity binding between proNGF, sortilin, and

c-Jun N-terminal kinase (JNK); which phosphorylates c-Jun. The activated transcription factor c-Jun regulates nuclear transcription via AP-1 to increase pro-apoptotic gene transcription.[7]

Proliferation of pancreatic beta cells

There is evidence that pancreatic beta cells express both the TrkA and p75NTR receptors of NGF. It has been shown that the withdrawal of NGF induces apoptosis in pancreatic beta cells, signifying that NGF may play a critical role in the maintenance and survival of pancreatic beta cells.[8]

Regulation of the immune system

NGF plays a critical role in the regulation of both innate and acquired immunity. In the process of inflammation, NGF is released in high concentrations by mast cells, and induces axonal outgrowth in nearby nociceptive neurons. This leads to increased pain perception in areas under inflammation. In acquired immunity, NGF is produced by the Thymus as well as CD4+ T cell clones, inducing a cascade of maturation of T cells under infection.[9]

Ovulation

NGF is abundant in seminal plasma. Recent studies have found that it induces ovulation in some mammals e.g. "induced" ovulators, such as llamas. Surprisingly, research showed that these induced animals will also ovulate when semen from on-schedule or "spontaneous" ovulators, such as cattle is used. Its significance in humans is unknown. It was previously dubbed ovulation-inducing factor (OIF) in semen before it was identified as beta-NGF in 2012.[10]

Mechanism of action

NGF binds with at least two classes of receptors: the

neurodegenerative disorders
.

When NGF binds to the TrkA receptor, it drives the homodimerization of the receptor, which in turn causes the autophosphorylation of the tyrosine kinase segment.

ras, and PLC signaling pathways.[13]
Alternatively, the p75NTR receptor can form a heterodimer with TrkA, which has higher affinity and specificity for NGF.

Studies suggest that NGF circulates throughout the entire body via the blood plasma, and is important for the overall maintenance of homeostasis.[14]

Neuron survival

Binding interaction between NGF and the TrkA receptor facilitates receptor dimerization and tyrosine residue phosphorylation of the cytoplasmic tail by adjacent Trk receptors.[15] Trk receptor phosphorylation sites operate as Shc adaptor protein docking sites, which undergo phosphorylation by the TrkA receptor[7] Once the cytoplasmic adaptor protein (Shc) is phosphorylated by the receptor cytoplasmic tail, cell survival is initiated through several intracellular pathways.

One major pathway leads to the activation of the serine/threonine kinase,

PI3K) is activated, resulting in Akt kinase activation.[7] Study results have shown that blocking PI3K or Akt activity results in death of sympathetic neurons in culture, regardless of NGF presence.[16] However, if either kinase is constitutively active, neurons survive even without NGF.[16]

A second pathway contributing to cell survival occurs through activation of the mitogen-activated protein kinase (

Raf.[7] Raf in turn activates the MAPK cascade to facilitate ribosomal s6 kinase (RSK) activation and transcriptional regulation.[7]

Both Akt and RSK, components of the PI3K-Akt and MAPK pathways respectively, act to phosphorylate the cyclic AMP response element binding protein (

c-Jun are not suppressed by the aforementioned NGF-mediated cell survival pathways.[7]

History

Rita Levi-Montalcini and Stanley Cohen discovered NGF in the 1950s while faculty members at Washington University in St. Louis. The critical discover was done by Levi-Montalcini and Hertha Meyer at the Carlos Chagas Filho Biophysics Institute of the Federal University of Rio de Janeiro in 1952. Their publication in 1954[17] became the definitive proof for the existence of the protein.[18][19] Levi-Montalcini later remarked:

The tumor had given a first hint of its existence in St. Louis but it was in Rio de Janeiro that it revealed itself, and it did so in a theatrical and grand way, as if spurred by the bright atmosphere of that explosive and exhuberant manifestation of life that is the Carnival in Rio.[20]

However, its discovery, along with the discovery of other neurotrophins, was not widely recognized until 1986, when it won the Nobel Prize in Physiology or Medicine.[21][22][23]

Studies in 1971 determined the

primary structure
of NGF. This eventually led to the discovery of the NGF gene.

NGF is abundant in seminal plasma. Recent studies have found that it induces ovulation in some mammals.[24] Nerve Growth Factors (NGF) were initially discovered due to their actions during development, but NGF are now known to be involved in the function throughout the life of the animal.[25]

Interactions

Nerve growth factor has been shown to

Clinical Use

NGF, specifically mouse (murine) nerve growth factor, has been available as a licensed medicine in China since 2003.[27] There is evidence of improved patient outcomes for several diseases of the nervous system, including acute intracerebral hemorrhage,[28] global developmental delay,[29] optic atrophy,[30] epilepsy [31] and cerebral palsy.[32] This is significant as there are few medicines which can treat injuries and diseases of the nervous system. Research and clinical use outside of China is limited despite a large body of evidence supporting its use.

See also

References

  1. ^ a b c GRCh38: Ensembl release 89: ENSG00000134259Ensembl, May 2017
  2. ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000027859Ensembl, May 2017
  3. ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. PMID 14699960
    .
  6. .
  7. ^ .
  8. .
  9. .
  10. .
  11. ^
    PMID 24023598
    .
  12. .
  13. .
  14. .
  15. .
  16. ^ .
  17. from the original on 2024-01-11. Retrieved 2024-01-11.
  18. from the original on 2024-01-11. Retrieved 2024-01-11.
  19. from the original on 2024-01-11. Retrieved 2024-01-11.
  20. from the original on 2024-01-11. Retrieved 2024-01-11.
  21. ^ "The 1986 Nobel Prize in Physiology or Medicine for discoveries of growth factors". Archived from the original on 2008-12-02. Retrieved 2005-11-30.
  22. ^ Presentation Speech by Professor Kerstin Hall The Nobel Prize in Physiology or Medicine 1986 Archived 2008-10-13 at the Wayback Machine
  23. ^ "Rita Levi-Montalcini – Nobel Lecture". Archived from the original on 2008-08-28. Retrieved 2005-11-30.
  24. ^ "Ovulation spurred by newfound semen ingredient". 20 August 2012. Archived from the original on 2021-10-28. Retrieved 2021-10-28.
  25. ^ Adelman, George. Encyclopedia of Neuroscience . Boston: Birkhhaeuser, 1987. Print.[ISBN missing][page needed]
  26. S2CID 4343450
    .
  27. .
  28. .
  29. from the original on 2023-01-20. Retrieved 2024-02-23.
  30. .
  31. .
  32. .

External links